Wells Fargo Maintains Overweight on Sabra Health Care REIT, Raises Price Target to $22

Wells Fargo analyst John Kilichowski has maintained an Overweight rating on Sabra Health Care REIT (NASDAQ: SBRA) and raised the price target from $21 to $22. This adjustment reflects a positive outlook for the company in the market.